Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier

Molecular Pharmacology

Volumn 78, Issue 3, 2010, Pages 376-383

  Wang, Xueqian ^a   Sykes, Destiny B ^a   Miller, David S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; ADENOSINE TRIPHOSPHATE; BREAST CANCER RESISTANCE PROTEIN; CONSTITUTIVE ANDROSTANE RECEPTOR; ESTERASE INHIBITOR; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; PHENOBARBITAL; CARRIER PROTEIN; CELL RECEPTOR; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION TERMINATION; TRANSLATION REGULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BRAIN; C3H MOUSE; CAPILLARY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; SPRAGUE DAWLEY RAT; TRANSCRIPTION INITIATION; TRANSPORT AT THE CELLULAR LEVEL; VASCULARIZATION;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARIES; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; XENOBIOTICS;

EID: 77956237647     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.063685     Document Type: Article

References (35)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, and Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37:13-25.
2. Akanuma S, Hori S, Ohtsuki S, Fujiyoshi M, and Terasaki T (2008) Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier. Neurochem Int 52:669-674.
3. Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, Reid G, Schellens JH, Koomen GJ, and Schinkel AH (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther 1:417-425.
4. Anapolsky A, Teng S, Dixit S, and Piquette-Miller M (2006) The role of pregnane X receptor in 2-acetylaminofluorene-mediated induction of drug transport and -metabolizing enzymes in mice. Drug Metab Dispos 34:405-409. (Pubitemid 43290899)
5. Bauer B, Hartz AM, Fricker G, and Miller DS (2004) Pregnane X receptor upregulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 66:413-419. (Pubitemid 39329239)
6. Bauer B, Hartz AM, Lucking JR, Yang X, Pollack GM, and Miller DS (2008) Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J Cereb Blood Flow Metab 28:1222-1234. (Pubitemid 351733346)
7. Bauer B, Yang X, Hartz AM, Olson ER, Zhao R, Kalvass JC, Pollack GM, and Miller DS (2006) In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Mol Pharmacol 70:1212-1219. (Pubitemid 44435972)
8. Burk O, Arnold KA, Geick A, Tegude H, and Eichelbaum M (2005) A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem 386:503-513. (Pubitemid 41447572)
9. Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, and Declèves X (2008) ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 107:1518-1528.
10. Hartz AM, Bauer B, Fricker G, and Miller DS (2004) Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Mol Pharmacol 66:387-394. (Pubitemid 39329237)
11. Jackson JP, Ferguson SS, Negishi M, and Goldstein JA (2006) Phenytoin induction of the cyp2c37 gene is mediated by the constitutive androstane receptor. Drug Metab Dispos 34:2003-2010. (Pubitemid 44837761)
12. Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, and Fardel O (2006) Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756-1763. (Pubitemid 44427479)
13. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, and Edwards PA (2002) Regulation of multidrug resistance- associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277:2908-2915. (Pubitemid 34953324)
14. Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, and Negishi M (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19:6318-6322. (Pubitemid 29399336)
15. Koike C, Moore R, and Negishi M (2005) Localization of the nuclear receptor CAR at the cell membrane of mouse liver. FEBS Lett 579:6733-6736. (Pubitemid 41773678)
16. Lamba JK, Lamba V, Yasuda K, Lin YS, Assem M, Thompson E, Strom S, and Schuetz E (2004) Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther 311:811-821. (Pubitemid 39391571)
17. Lombardo L, Pellitteri R, Balazy M, and Cardile V (2008) Induction of nuclear receptors and drug resistance in the brain microvascular endothelial cells treated with antiepileptic drugs. Curr Neurovasc Res 5:82-92. (Pubitemid 351838572)
18. Miller DS, Bauer B, and Hartz AM (2008) Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 60:196-209. (Pubitemid 351962009)
19. Miller DS, Nobmann SN, Gutmann H, Toeroek M, Drewe J, and Fricker G (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol 58:1357-1367.
20. Moore JT, Moore LB, Maglich JM, and Kliewer SA (2003) Functional and structural comparison of PXR and CAR. Biochim Biophys Acta 1619:235-238.
21. Nannelli A, Chirulli V, Longo V, and Gervasi PG (2008) Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 252:105-112.
22. Rezen T, Tamasi V, Lövgren-Sandblom A, Björkhem I, Meyer UA, and Rozman D (2009) Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers. BMC Genomics 10:384.
23. Schramm U, Fricker G, Wenger R, and Miller DS (1995) P-glycoprotein- mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am J Physiol 268:F46-F52.
24. Shukla S, Zaher H, Hartz A, Bauer B, Ware JA, and Ambudkar SV (2009) Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm Res 26:480-487.
25. Stanley LA, Horsburgh BC, Ross J, Scheer N, and Wolf CR (2006) PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev 38:515-597.
26. Timsit YE and Negishi M (2007) CAR and PXR: the xenobiotic-sensing receptors. Steroids 72:231-246.
27. Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann JM, and Negishi M (2002) Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 61:1-6.
28. Wang H and Negishi M (2003) Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors. Curr Drug Metab 4:515-525.
29. Wei P, Zhang J, Dowhan DH, Han Y, and Moore DD (2002) Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J 2:117-126.
30. Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, and Evans RM (2000) Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 14:3014-3023.
31. Xiong H, Yoshinari K, Brouwer KL, and Negishi M (2002) Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. Drug Metab Dispos 30:918-923.
32. Xu C, Li CY, and Kong AN (2005) Induction of phase I, II and III drug metabolism/ transport by xenobiotics. Arch Pharm Res 28:249-268.
33. Yoshinari K, Kobayashi K, Moore R, Kawamoto T, and Negishi M (2003) Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett 548:17-20.
34. Zelko I, Sueyoshi T, Kawamoto T, Moore R, and Negishi M (2001) The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol Cell Biol 21:2838-2846.
35. Zollner G and Trauner M (2009) Nuclear receptors as therapeutic targets in cholestatic liver diseases. Br J Pharmacol 156:7-27.